# Lisdexamfetamine Dimesylate

NDC: 64850-554
Generic name: lisdexamfetamine dimesylate
Labeler / Manufacturer: Elite Laboratories, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20241115

FDA application: ANDA218604

## Active ingredients

- LISDEXAMFETAMINE DIMESYLATE: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"64850-554"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=64850-554
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e024b69-567c-4b40-9c3e-a2daec34256c